Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Parker-Hannifin CorpPH · Entity 2887 | Director | February 10, 2011 | February 14, 2011 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Parker-Hannifin Corp
Report date February 10, 2011 · Filed February 14, 2011
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,041 |
Ending reported balance
After 2011-02-10 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2011-02-10 · Sale · Disposed 600 · Balance 15,441 Row 2 · 2011-02-10 · Sale · Disposed 1,666 · Balance 13,775 Row 3 · 2011-02-10 · Sale · Disposed 17 · Balance 13,758 Row 4 · 2011-02-10 · Sale · Disposed 17 · Balance 13,741 Row 5 · 2011-02-10 · Sale · Disposed 700 · Balance 13,041 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Xylem Inc.
Report date May 18, 2023 · Filed May 19, 2023
Section 16 reporting ended · disclosed 2023-05-19. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 12, 2022 Filed May 16, 2022 19:00 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 1,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029346 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,140 F1 · shares: Reflects the award of restricted stock units which are scheduled to vest the day before the 2023 Annual Shareowner Meeting. Read SEC document |
| December 21, 2021 Filed Feb 7, 2022 16:10 UTC | Xylem Inc. XYL · Entity 430 | GiftCommon Stock | 2,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007426 · doc5.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Tambakeras Family Trust Disclosed balance after: 27,639 F1 · shares: On December 21, 2021, 2,577 shares of Xylem Inc. common stock were transferred from the reporting person's individual account to the Tambakeras Family Trust. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 16:03 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 5,000 | $131.96 | $659,799.00 |
DisclosureSEC source: 0001209191-21-056152 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Tambakeras Family Trust Disclosed balance after: 25,062 F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a range of prices from $131.94 to $132.01. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 16:03 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 3,000 | $119.12 | $357,360.30 |
DisclosureSEC source: 0001209191-21-037119 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Tambakeras Family Trust Disclosed balance after: 30,062 F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| May 12, 2021 Filed May 13, 2021 16:42 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 1,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032369 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,575 F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2022 annual shareholders' meeting. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 17:14 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 5,000 | $102.02 | $510,106.50 |
DisclosureSEC source: 0001209191-21-021437 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Tambakeras Family Trust Disclosed balance after: 33,062 F1 · price: This price represents the weighted average price per Share of the Issuer. Shares were executed at a price $102.0213 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 16:47 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 5,000 | $99.00 | $495,000.00 |
DisclosureSEC source: 0001209191-20-063817 · doc4.xml · nonDerivative · entry 2 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Tambakeras Family Trust Disclosed balance after: 38,062 F2 · price: This price represents the weighted average price per Share of the Issuer. Shares were executed at a price $99.00 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. F1 · balance_after: The reporting officer transferred 6,777.513 shares from his GRAT to the Tambakeras Family Trust on October 16, 2020. Read SEC document |
| October 16, 2020 Filed Dec 16, 2020 16:47 UTC | Xylem Inc. XYL · Entity 430 | GiftCommon Stock | 6,777 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-063817 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Tambakeras 2018 Grantor Retained Annuity Trust Disclosed balance after: 0 F1 · shares: The reporting officer transferred 6,777.513 shares from his GRAT to the Tambakeras Family Trust on October 16, 2020. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 16:51 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 6,050 | $85.23 | $515,647.55 |
DisclosureSEC source: 0001209191-20-054023 · doc4.xml · nonDerivative · entry 2 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Tambakeras Family Trust Disclosed balance after: 36,285 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on September 2, 2020. F3 · price: This price represents the weighted average price per Share of the Issuer. Shares were executed at prices ranging from $85.00 to $85.56 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 16:51 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 700 | $85.00 | $59,502.52 |
DisclosureSEC source: 0001209191-20-054023 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Tambakeras Family Trust Disclosed balance after: 42,335 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on September 2, 2020. F2 · price: This price represents the weighted average price per Share of the Issuer. Shares were executed at a price $85.0036 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 17:29 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 14,000 | $80.20 | $1,122,822.40 |
DisclosureSEC source: 0001209191-20-046420 · doc4.xml · nonDerivative · entry 2 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Tambakeras Family Trust Disclosed balance after: 43,035 F2 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 10, 2020. F3 · price: This price represents the weighted average price per Share of the Issuer. 14,000 shares were shares were executed at prices ranging from $80.01 to $80.43 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 17:29 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 5,000 | $77.54 | $387,700.00 |
DisclosureSEC source: 0001209191-20-046420 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Tambakeras Family Trust Disclosed balance after: 57,035 F1 · balance_after: Reflects the addition of 2,714 shares transferred to the Tambakeras Family Trust on June 17, 2020 Read SEC document |
| May 13, 2020 Filed May 14, 2020 15:20 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 2,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029116 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,247 F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2021 annual shareholders' meeting. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 14:35 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,860 | $0.00 Strike: $30.03 | $0.00 |
DisclosureSEC source: 0001209191-19-055636 · doc4.xml · derivative · entry 5 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,860 shares Expires 2020-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 14:35 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 2,860 | $78.95 | $225,792.71 |
DisclosureSEC source: 0001209191-19-055636 · doc4.xml · nonDerivative · entry 2 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,670 F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $78.9477 to $78.9485 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. F3 · balance_after: The reporting person transferred 2,886 shares from his personal brokerage account to the Tambakeras family trust. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 14:35 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 2,860 | $30.03 | $85,884.37 |
DisclosureSEC source: 0001209191-19-055636 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These options are set to expire on March 5, 2020. Read SEC document |
| May 15, 2019 Filed May 17, 2019 15:57 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 2,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030840 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,670 F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2020 annual shareholders' meeting. Read SEC document |
| December 21, 2018 Filed Feb 15, 2019 15:31 UTC | Xylem Inc. XYL · Entity 430 | GiftCommon Stock | 4,065 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-010521 · doc5.xml · nonDerivative · entry 2 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Tambakeras Family Trust Disclosed balance after: 56,455 F3 · shares: On December 21, 2018, 4,065 shares of Xylem Inc. common stock were gifted from the reporting person's personal brokerage account to the Tambakeras Family Trust, of which the reporting person is the sole beneficiary. F4 · balance_after: Reflects a transfer of 31,005 shares of Xylem Inc. common stock from the reporting person's personal brokerage account to the Tambakeras Family Trust, of which the reporting person is the sole beneficiary. Read SEC document |
| August 08, 2018 Filed Feb 15, 2019 15:31 UTC | Xylem Inc. XYL · Entity 430 | GiftCommon Stock | 6,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-010521 · doc5.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Tambakeras 2018 Grantor Retained Annuity Trust Disclosed balance after: 6,620 F1 · shares: On August 8, 2018, 6,599 shares of Xylem Inc. common stock were transferred from the reporting person's family trust to the reporting person's 2018 Grantor Retained Annuity Trust account. F2 · balance_after: An additional 20 shares accrued through a qualified DRIP. Read SEC document |
| May 09, 2018 Filed May 10, 2018 12:55 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 2,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-029121 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,956 F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2019 annual shareholders' meeting. Read SEC document |
| August 23, 2017 Filed Feb 14, 2018 17:23 UTC | Xylem Inc. XYL · Entity 430 | GiftCommon Stock | 9,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-009997 · doc5.xml · nonDerivative · entry 2 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Tambakeras Family Trust Disclosed balance after: 27,964 F1 · balance_after: On August 23, 2017, 9512 shares of Xylem Inc. common stock were gifted to the reporting person's revocable family trust. Read SEC document |
| August 23, 2017 Filed Feb 14, 2018 17:23 UTC | Xylem Inc. XYL · Entity 430 | GiftCommon Stock | 9,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-009997 · doc5.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,070 Read SEC document |
| May 10, 2017 Filed May 11, 2017 19:56 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 4,065 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031670 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,582 F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2018 annual shareholders' meeting. Read SEC document |
| February 10, 2011 Filed Feb 14, 2011 20:51 UTC | Parker-Hannifin Corp PH · Entity 2887 | SaleCommon Stock | 700 | $91.44 | $64,008.00 |
DisclosureSEC source: 0000076334-11-000011 · edgar.xml · nonDerivative · entry 5 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,041 Read SEC document |
| February 10, 2011 Filed Feb 14, 2011 20:51 UTC | Parker-Hannifin Corp PH · Entity 2887 | SaleCommon Stock | 17 | $91.43 | $1,554.31 |
DisclosureSEC source: 0000076334-11-000011 · edgar.xml · nonDerivative · entry 4 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,741 Read SEC document |
| February 10, 2011 Filed Feb 14, 2011 20:51 UTC | Parker-Hannifin Corp PH · Entity 2887 | SaleCommon Stock | 17 | $91.42 | $1,554.14 |
DisclosureSEC source: 0000076334-11-000011 · edgar.xml · nonDerivative · entry 3 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,758 Read SEC document |
| February 10, 2011 Filed Feb 14, 2011 20:51 UTC | Parker-Hannifin Corp PH · Entity 2887 | SaleCommon Stock | 1,666 | $91.41 | $152,289.06 |
DisclosureSEC source: 0000076334-11-000011 · edgar.xml · nonDerivative · entry 2 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,775 Read SEC document |
| February 10, 2011 Filed Feb 14, 2011 20:51 UTC | Parker-Hannifin Corp PH · Entity 2887 | SaleCommon Stock | 600 | $91.40 | $54,840.00 |
DisclosureSEC source: 0000076334-11-000011 · edgar.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,441 Read SEC document |
| October 01, 2010 Filed Oct 1, 2010 13:36 UTC | Parker-Hannifin Corp PH · Entity 2887 | GrantCommon Stock | 1,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000076334-10-000079 · edgar.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,041 Read SEC document |
| December 03, 2009 Filed Dec 7, 2009 20:27 UTC | Parker-Hannifin Corp PH · Entity 2887 | GrantOption to Buy · Derivative | 3,303 | $0.00 Strike: $54.23 | $0.00 |
DisclosureSEC source: 0000076334-09-000078 · edgar.xml · derivative · entry 3 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,303 Underlying: Common Stock · 3,303 shares Expires 2015-08-09 F3 · price: Granted under the Corporation's 2004 Non-Employee Directors' Stock Incentive Plan in a transaction exempt under Rule 16b-3. Read SEC document |
| December 03, 2009 Filed Dec 7, 2009 20:27 UTC | Parker-Hannifin Corp PH · Entity 2887 | Exercise / conversionOption to Buy · Derivative | 4,125 | $0.00 Strike: $43.77 | $0.00 |
DisclosureSEC source: 0000076334-09-000078 · edgar.xml · derivative · entry 2 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,125 shares Expires 2015-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: "Pyramid" stock option exercise resulting in net acquisition of 822 shares. F3 · price: Granted under the Corporation's 2004 Non-Employee Directors' Stock Incentive Plan in a transaction exempt under Rule 16b-3. F2 · derivative.exercise_date: The option vested in two equal installments on August 10, 2006 and August 10, 2007. F1 · derivative.underlying_shares: "Pyramid" stock option exercise resulting in net acquisition of 822 shares. Read SEC document |
| December 03, 2009 Filed Dec 7, 2009 20:27 UTC | Parker-Hannifin Corp PH · Entity 2887 | Exercise / conversionCommon Stock | 822 | $43.77 | $35,976.23 |
DisclosureSEC source: 0000076334-09-000078 · edgar.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,421 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: "Pyramid" stock option exercise resulting in net acquisition of 822 shares. Read SEC document |
| October 01, 2009 Filed Oct 1, 2009 19:38 UTC | Parker-Hannifin Corp PH · Entity 2887 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000076334-09-000068 · edgar.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,599 F1 · kind: Award of restricted stock under the Corporation's 2004 Non-Employee Directors' Stock Incentive Plan in a transaction exempt under Rule 16b-3. F1 · price: Award of restricted stock under the Corporation's 2004 Non-Employee Directors' Stock Incentive Plan in a transaction exempt under Rule 16b-3. Read SEC document |
| October 01, 2008 Filed Oct 2, 2008 14:37 UTC | Parker-Hannifin Corp PH · Entity 2887 | GrantCommon Stock | 1,350 | $0.00 | $0.00 |
DisclosureSEC source: 0000076334-08-000097 · edgar.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,599 F1 · kind: Award of restricted stock under the Corporation's 2004 Non-Employee Directors' Stock Incentive Plan in a transaction exempt under Rule 16b-3. F1 · price: Award of restricted stock under the Corporation's 2004 Non-Employee Directors' Stock Incentive Plan in a transaction exempt under Rule 16b-3. Read SEC document |
| October 01, 2007 Filed Oct 3, 2007 20:16 UTC | Parker-Hannifin Corp PH · Entity 2887 | GrantCommon Stock | 1,650 | $0.00 | $0.00 |
DisclosureSEC source: 0000076334-07-000107 · edgar.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,249 F1 · kind: Award of restricted stock under the Corporation's 2004 Non-Employee Directors' Stock Incentive Plan in a transaction exempt under Rule 16b-3. F1 · price: Award of restricted stock under the Corporation's 2004 Non-Employee Directors' Stock Incentive Plan in a transaction exempt under Rule 16b-3. F2 · balance_after: Reflects 3-shares-for-2 stock split effected in the form of a stock dividend issued on October 1, 2007. Read SEC document |
| January 03, 2007 Filed Jan 4, 2007 20:23 UTC | Parker-Hannifin Corp PH · Entity 2887 | GrantCommon Stock | 2,942 | $77.07 | $226,725.23 |
DisclosureSEC source: 0000076334-07-000003 · edgar.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,733 F1 · kind: Conversion of one hundred percent of Mr. Tambakeras' retainer for his three-year term of office into restricted stock pursuant to the Corporation's Amended and Restated Non-Employee Directors' Stock Plan in a transaction exempt under Rule 16b-3. Read SEC document |
| October 01, 2006 Filed Oct 3, 2006 18:08 UTC | Parker-Hannifin Corp PH · Entity 2887 | GrantCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0000076334-06-000095 · edgar.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,791 F1 · kind: - Award of restricted stock under the Corporation's Non-Employee Directors' 2004 Stock Incentive Plan in a transaction exempt under Rule 16b-3. F1 · price: - Award of restricted stock under the Corporation's Non-Employee Directors' 2004 Stock Incentive Plan in a transaction exempt under Rule 16b-3. Read SEC document |
| August 10, 2005 Filed Aug 11, 2005 18:32 UTC | Parker-Hannifin Corp PH · Entity 2887 | GrantOption to buy · Derivative | 2,750 | $0.00 Strike: $65.65 | $0.00 |
DisclosureSEC source: 0000076334-05-000045 · edgar.xml · derivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,750 Underlying: Common Stock · 2,750 shares Expires 2015-08-09 F2 · price: Granted under the Corporation's 2004 Non-Employee Directors' Stock Incentive Plan in a transaction exempt under Rule 16b-3. F1 · derivative.exercise_date: The option vests in two equal installments on 8/10/2006 and 8/10/2007. Read SEC document |
| April 20, 2005 Filed Apr 21, 2005 14:08 UTC | Parker-Hannifin Corp PH · Entity 2887 | GrantCommon Stock | 1,666 | $60.78 | $101,251.15 |
DisclosureSEC source: 0000076334-05-000014 · edgar.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director Elect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,666 F1 · kind: Conversion of one hundred percent of Mr. Tambakeras' retainer for his one and one-half year term of office into restricted stock pursuant to the Corporation's Non-Employee Directors' Stock Plan, as amended and restated, in a transaction exempt under Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.